-
Stoke Therapeutics (NASDAQ:STOK) Given Buy Rating at Needham & Company LLC
Source: Buzz FX / 06 Nov 2024 07:47:17 America/Chicago
Stoke Therapeutics (NASDAQ:STOK) Given Buy Rating at Needham & Company LLC Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Stoke Therapeutics ( NASDAQ:STOK - Get Free Report ) 's stock had its "buy" rating restated by
Read more...